MDxHealth SA
MDXH
$3.51
$0.113.09%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 6.10% | 5.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.10% | 5.23% | |||
| Cost of Revenue | 1.99% | 1.90% | |||
| Gross Profit | 8.70% | 7.44% | |||
| SG&A Expenses | -4.82% | -0.73% | |||
| Depreciation & Amortization | 0.23% | 18.17% | |||
| Other Operating Expenses | 4,109.09% | 72.50% | |||
| Total Operating Expenses | -0.21% | 0.26% | |||
| Operating Income | 24.36% | 15.09% | |||
| Income Before Tax | 37.36% | 5.92% | |||
| Income Tax Expenses | -86.05% | -- | |||
| Earnings from Continuing Operations | 38.86% | 2.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 38.86% | 2.94% | |||
| EBIT | 24.36% | 15.09% | |||
| EBITDA | 38.77% | 26.65% | |||
| EPS Basic | 65.00% | 4.76% | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | 65.00% | 4.76% | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 74.69% | 1.92% | |||
| Average Diluted Shares Outstanding | 74.69% | 1.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||